Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Achaogen
Biotech
Achaogen seeks near-term sale through bankruptcy process
Achaogen has identified Chapter 11 bankruptcy as its best hope of getting some money for its assets.
Nick Paul Taylor
Apr 16, 2019 8:25am
Achaogen cuts costs again and puts up ‘for sale’ sign
Nov 6, 2018 9:45am
Chutes & Ladders—Cell Medica names Kite's European chief as CEO
Aug 3, 2018 9:43am
Achaogen wields ax as first launch gets underway
Jul 27, 2018 9:20am
Achaogen slides after adcomm verdict on plazomicin
May 3, 2018 8:26am
Achaogen's lead antibiotic aces pivotal trials
Dec 13, 2016 7:29am
